NASDAQ:ADAP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVT, PTRS, ROCC, ADAP

Retrieved on: 
Thursday, April 13, 2023

If you are a Cvent shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Cvent shareholder, click here to learn more about your rights and options .
  • If you are a Partners shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – CNXC, INDT, HSKA, ADAP

Retrieved on: 
Wednesday, April 12, 2023

Under the terms of the agreement, CNXC shareholders are expected to own approximately 78% of the combined company.

Key Points: 
  • Under the terms of the agreement, CNXC shareholders are expected to own approximately 78% of the combined company.
  • INDUS Realty Trust, Inc. (NASDAQ: INDT ), relating to its proposed sale to affiliates of Centerbridge Partners, L.P. and GIC Real Estate, Inc..
  • Adaptimmune Therapeutics plc (NASDAQ: ADAP ), relating to its proposed merger with TCR² Therapeutics Inc.
  • Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – MLVF, SAL, ADAP, BRBW

Retrieved on: 
Wednesday, April 5, 2023

Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Salisbury Bancorp, Inc. (NASDAQ: SAL ), relating to its proposed merger NBT Bancorp, Inc.
  • Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diffusion Pharmaceuticals Inc. (Nasdaq- DFFN), U.S. Xpress Enterprises, Inc. (NYSE – USX), TCR² Therapeutics Inc. (Nasdaq – TCRR), Costar Technologies, Inc. (OTC – CS

Retrieved on: 
Thursday, March 30, 2023

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the deal, Diffusion will merge with EIP Pharma Inc. (“EIP Pharma”).
  • Under the terms of the agreement, U.S. Express will be acquired by Knight-Swift Transportation Holdings Inc. (NYSE - KNX) (“Knight-Swift”).
  • U.S. Xpress stockholders will receive $6.15 per share in an all-cash transaction, representing an enterprise value of approximately $808 million.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USX, RADI, ROCC, ADAP

Retrieved on: 
Thursday, March 30, 2023

If you are a U.S. Xpress shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a U.S. Xpress shareholder, click here to learn more about your rights and options .
  • If you are a Radius shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – ADAP, SAL, BRBW, MLVF

Retrieved on: 
Wednesday, March 29, 2023

Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.

Key Points: 
  • Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.
  • Salisbury Bancorp, Inc. (NASDAQ: SAL ), relating to its proposed merger NBT Bancorp, Inc.
  • Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own.
  • Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RADI, DSEY, ADAP, TCRR

Retrieved on: 
Friday, March 24, 2023

If you are a Radius shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Radius shareholder, click here to learn more about your rights and options .
  • If you are a Diversey shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – MLVF, ADAP, BRBW, SAL

Retrieved on: 
Wednesday, March 22, 2023

Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, MLVF shareholders will receive 0.7733 shares of First Bank and $7.80 in cash per share they own.
  • Adaptimmune Therapeutics plc (NASDAQ: ADAP ), relating to its proposed merger with TCR² Therapeutics Inc.
  • Salisbury Bancorp, Inc. (NASDAQ: SAL ), relating to its proposed merger NBT Bancorp, Inc.
  • Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGEN, ADAP, PRVB, XM

Retrieved on: 
Sunday, March 19, 2023

If you are a Seagen shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Seagen shareholder, click here to learn more about your rights and options .
  • If you are a Adaptimmune shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP

Retrieved on: 
Sunday, March 19, 2023

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.

Key Points: 
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRVB to Sanofi S.A. for $25.00 per share in cash.
  • Lifshitz L aw PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.